Program Overview
Alopecia areata (AA) is a
form of nonscarring hair loss. While not life-threatening or painful, its
cosmetic manifestations have profound negative influence on patients’
psychological status and relationships. There are no specific systemic
therapies approved for AA, and the condition is currently managed with a
variety of off-label options that provide variable efficacy and potential risky
adverse effects. An improved understanding of disease etiology has led to the
development of new therapies that target pathological pathways involved in AA,
including the Janus kinase (JAK)/signal transducer and activator of
transcription signaling pathway. This webinar will review the clinical
manifestations and assessment of AA, along with clinical trial results with oral
JAK inhibitors, which are showing promise. This program has been created for US
dermatology allied healthcare professionals (HCPs) and will include several
interactive case study discussions.
Target Audience
This initiative is
intended for US dermatology allied HCPs, including physician assistants, nurse
practitioners, and nurses, as well as other allied HCPs who may be involved in
the management of patients with AA.
Educational Objectives
Upon completion of this activity, the learner should be able to:
Agenda
Brett King, MD, PhD
Associate Professor of DermatologyYale
School of Medicine
New Haven, CT
Sharna
Givans, DNP, APRN, FNP-BC
Tampa,
FL
Douglas DiRuggiero,
DMSc, PA-C
Skin Cancer and Cosmetic Dermatology Center
Rome, GA
Disclosure
It is the
policy of AKH Inc. to ensure independence, balance, objectivity, scientific
rigor, and integrity in all of its continuing education activities. The author
must disclose to the participants any significant relationships with ineligible
companies whose products or devices may be mentioned in the activity or with
the commercial supporter of this continuing education activity. Identified
conflicts of interest are mitigated by AKH prior to accreditation of the
activity. AKH planners and reviewers have no relevant financial relationships
to disclose.
Criteria for Success
Certificates
of completion will be awarded based on the participant’s attendance and
submission of the activity evaluation/claim credit form. You must participate
in the entire activity to receive credit. There is no fee to participate in
this activity. If you have questions about this activity, please contact AKH
Inc. at tbrignoni@akhcme.com.
Credit provided by AKH Inc.,
Advancing Knowledge in Healthcare
In support of improving patient
care, this activity has been planned and implemented by AKH Inc., Advancing
Knowledge in Healthcare and Catalyst Medical Education, LLC. AKH Inc.,
Advancing Knowledge in Healthcare is jointly accredited by the Accreditation
Council for Continuing Medical Education (ACCME), the Accreditation Council for
Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC),
to provide continuing education for the healthcare team.
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a
maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should
claim only the credit commensurate with the extent of their participation in
the activity.
Physician Assistants 
AKH Inc.,
Advancing Knowledge in Healthcare has been authorized by the American Academy
of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in
accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA
Category 1 CME credits. PAs should only claim credit commensurate with the
extent of their participation.
Nurses
1.5 ANCC contact hours.
Nurse
Practitioners
This activity has been planned and implemented
in accordance with the Accreditation Standards of the American Association of
Nurse Practitioners (AANP) through the joint providership of AKH Inc.,
Advancing Knowledge in Healthcare and Catalyst Medical Education, LLC. AKH
Inc., Advancing Knowledge in Healthcare is accredited by the American Association
of Nurse Practitioners as an approved provider of nurse practitioner continuing
education. Provider number: 030803.
This activity is approved for 1.5 contact hour(s) (which
includes 0.5 hour(s) of pharmacology).
Provider Information
This program is jointly provided by AKH Inc., Advancing Knowledge in Healthcare
and Catalyst Medical Education, LLC.
Commercial Support:
This activity is supported by an educational grant from Pfizer, Inc.
Disclaimer
This course is designed solely to provide the healthcare professional with
information to assist in his/her practice and professional development and is
not to be considered a diagnostic tool to replace professional advice or
treatment. The course serves as a general guide to the healthcare professional,
and therefore, cannot be considered as giving legal, nursing, medical, or other
professional advice in specific cases. AKH Inc. specifically disclaim
responsibility for any adverse consequences resulting directly or indirectly
from information in the course, for undetected error, or through participant's
misunderstanding of the content.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are
investigational and/or unapproved by the FDA. Please refer to the official
prescribing information for each product for discussion of approved
indications, contraindications, and warnings.
AKH Privacy Policy (link: https://akhcme.com/akhcme/pages/privacy)
